Cargando…
Drug Investigation to Dampen the Comorbidity of Rheumatoid Arthritis and Osteoporosis via Molecular Docking Test
At present, most rheumatoid arthritis (RA) patients are at risk of osteoporosis (OP), which is increased by 1.5 times compared to non-RA individuals. Hence, we investigated overlapping targets related directly to the occurrence and development of RA and OP through public databases (DisGeNET, and OMI...
Autores principales: | Oh, Ki-Kwang, Adnan, Md., Cho, Dong-Ha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8947408/ https://www.ncbi.nlm.nih.gov/pubmed/35723292 http://dx.doi.org/10.3390/cimb44030069 |
Ejemplares similares
-
New Insight into Drugs to Alleviate Atopic March via Network Pharmacology-Based Analysis
por: Oh, Ki-Kwang, et al.
Publicado: (2022) -
Can vagus nerve stimulation halt or ameliorate rheumatoid arthritis and lupus?
por: Das, Undurti N
Publicado: (2011) -
Does gamma-aminobutyric acid (GABA) influence the development of chronic inflammation in rheumatoid arthritis?
por: Kelley, James M, et al.
Publicado: (2008) -
Molecular Docking and Pharmacological Investigations of Rivastigmine-Fluoxetine and Coumarin–Tacrine hybrids against Acetyl Choline Esterase
por: Babitha, Pallikkara Pulikkal, et al.
Publicado: (2015) -
Molecular docking of azole drugs and their analogs on CYP121 of Mycobacterium tuberculosis
por: Sundaramurthi, Jagadish Chandrabose, et al.
Publicado: (2011)